Sleep Apnea
Adaptive servo-ventilation improves disease-specific life quality in central sleep apnea
WASHINGTON — Adults with central sleep apnea on adaptive servo-ventilation for 12 months had improved disease-specific quality of life, according to an abstract presented at the American Thoracic Society International Conference.
‘High efficacy’ with mandibular advancement device in new moderate to severe OSA
WASHINGTON — For patients with new moderate to severe obstructive sleep apnea, mandibular advancement device therapy reduced disorder severity, according to an abstract presented at the American Thoracic Society International Conference.
Pulse oximeters may misjudge sleep apnea severity in Black patients
WASHINGTON — Black patients had decreased desaturation sensitivity during sleep recorded by pulse oximeters, according to research presented at the American Thoracic Society International Conference.
Obstructive sleep apnea may affect RNFL thickness, IOP
Obstructive sleep apnea may have an impact on retinal nerve fiber layer thickness and IOP, highlighting the importance of screening affected individuals for glaucoma, according to data published in the Journal of Glaucoma.
Top news of May: Obstructive sleep apnea drug combination, central sleep apnea mortality
Healio has compiled the most-read news in pulmonology posted in May.
FDA grants MRI conditional use for implantable sleep apnea therapy
The FDA has granted conditional use with MRI to an implantable transvenous phrenic nerve stimulation therapy for adults with moderate to severe central sleep apnea.
Sleep apnea may increase risk for long COVID
People with obstructive sleep apnea, particularly those with other chronic conditions, had a significantly increased risk for developing long COVID after a SARS-CoV-2 infection compared with those without obstructive sleep apnea, data show.
CPAP improves cognition in patients with Parkinson’s disease, obstructive sleep apnea
WASHINGTON — Among patients with Parkinson’s disease, obstructive sleep apnea and decreased cognition, CPAP therapy improved cognitive function, according to an abstract presented at the American Thoracic Society International Conference.
Oral combination obstructive sleep apnea drug lowers disorder severity over 1 month
WASHINGTON — A combination of atomoxetine and aroxybutynin taken for 4 weeks lessened obstructive sleep apnea severity, according to an abstract presented at the American Thoracic Society International Conference.
Sunosi 'likely superior' treatment for daytime sleepiness in patients with sleep apnea
Sunosi, Wakix and armodafinil-modafinil reduced excessive daytime sleepiness in patients with obstructive sleep apnea who are already receiving conventional therapy, with Sunosi being “likely superior,” according to researchers.